Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aleix Prat

Showing results (31-40 of 326) with videos related to

Pageof 33
Sort By:
Cancer Treatment Reviews|October 21, 2023
AXL - a new player in resistance to HER2 blockadeAnna Adam-Artigues, Enrique J Arenas, Joaquín Arribas, et al.
Journal of the National Cancer Institute|February 27, 2015
ResponseWilliam F Anderson, Philip S Rosenberg, Aleix Prat, et al.
Journal of the National Cancer Institute|August 14, 2014
How many etiological subtypes of breast cancer: two, three, four, or more?William F Anderson, Philip S Rosenberg, Aleix Prat, et al.
Spine|May 23, 2008
A rare case of malignant solitary fibrous tumor of the spinal cordEva Muñoz, Aleix Prat, Barbara Adamo, et al.
The Lancet. Oncology|August 7, 2010
Clinical implementation of the intrinsic subtypes of breast cancerCharles M Perou, Joel S Parker, Aleix Prat, et al.
Breast Cancer Research and Treatment|July 23, 2014
Molecular features of the basal-like breast cancer subtype based on BRCA1 mutation statusAleix Prat, Cristina Cruz, Katherine A Hoadley, et al.
Future Oncology (London, England)|September 2, 2016
Ipilimumab after progression on anti-PD-1 treatment in advanced melanomaFrancisco Aya, Lydia Gaba, Iván Victoria, et al.
Nature Communications|January 29, 2025
Unlocking the potential of engineered immune cell therapy for solid tumorsVíctor Albarrán-Fernández, Laura Angelats, Julio Delgado, et al.
BMC Cancer|May 1, 2014
Phospho-kinase profile of triple negative breast cancer and androgen receptor signalingMaría D Cuenca-López, Juan C Montero, Jorge C Morales, et al.
The Oncologist|February 14, 2013
Molecular characterization of basal-like and non-basal-like triple-negative breast cancerAleix Prat, Barbara Adamo, Maggie C U Cheang, et al.
Pageof 33

Showing results (31-40 of 326) with videos related to

Sort By:
Pageof 33
Cancer Treatment Reviews|October 21, 2023
AXL - a new player in resistance to HER2 blockadeAnna Adam-Artigues, Enrique J Arenas, Joaquín Arribas, et al.
Journal of the National Cancer Institute|February 27, 2015
ResponseWilliam F Anderson, Philip S Rosenberg, Aleix Prat, et al.
Journal of the National Cancer Institute|August 14, 2014
How many etiological subtypes of breast cancer: two, three, four, or more?William F Anderson, Philip S Rosenberg, Aleix Prat, et al.
Spine|May 23, 2008
A rare case of malignant solitary fibrous tumor of the spinal cordEva Muñoz, Aleix Prat, Barbara Adamo, et al.
The Lancet. Oncology|August 7, 2010
Clinical implementation of the intrinsic subtypes of breast cancerCharles M Perou, Joel S Parker, Aleix Prat, et al.
Breast Cancer Research and Treatment|July 23, 2014
Molecular features of the basal-like breast cancer subtype based on BRCA1 mutation statusAleix Prat, Cristina Cruz, Katherine A Hoadley, et al.
Future Oncology (London, England)|September 2, 2016
Ipilimumab after progression on anti-PD-1 treatment in advanced melanomaFrancisco Aya, Lydia Gaba, Iván Victoria, et al.
Nature Communications|January 29, 2025
Unlocking the potential of engineered immune cell therapy for solid tumorsVíctor Albarrán-Fernández, Laura Angelats, Julio Delgado, et al.
BMC Cancer|May 1, 2014
Phospho-kinase profile of triple negative breast cancer and androgen receptor signalingMaría D Cuenca-López, Juan C Montero, Jorge C Morales, et al.
The Oncologist|February 14, 2013
Molecular characterization of basal-like and non-basal-like triple-negative breast cancerAleix Prat, Barbara Adamo, Maggie C U Cheang, et al.
Pageof 33